Showing results (151-160 of 162) with videos related to
Sort By:
Pageof 17
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 10, 2010
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivoAndrew D Chantry, Debby Heath, Aaron W Mulivor, et al.Haematologica|December 2, 2016
The myeloma stem cell concept, revisited: from phenomenology to operational termsHans Erik Johnsen, Martin Bøgsted, Alexander Schmitz, et al.Stem Cell Research & Therapy|December 1, 2020
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formationDan Zhang, Kim De Veirman, Rong Fan, et al.British Journal of Cancer|March 4, 2018
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cellsAngelique Bruyer, Ken Maes, Laurie Herviou, et al.Frontiers in Immunology|May 31, 2022
Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of MelanomaLien De Beck, Robin Maximilian Awad, Veronica Basso, et al.Blood|March 8, 2012
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like featuresAbdel Kareem Azab, Jinsong Hu, Phong Quang, et al.Journal for Immunotherapy of Cancer|May 16, 2020
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockadeRui Yang, Samah Elsaadi, Kristine Misund, et al.Nature Communications|December 4, 2015
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal nicheMichelle A Lawson, Michelle M McDonald, Natasa Kovacic, et al.Cell Reports|May 11, 2023
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironmentHannah Egan, Oliver Treacy, Kevin Lynch, et al.Blood|May 19, 2017
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myelomaMichelle M McDonald, Michaela R Reagan, Scott E Youlten, et al.Pageof 17